
|Articles|May 12, 2008
Cimzia approved for signs and symptoms of Crohn's disease
UCB receives FDA approval for certolizumab pegol (Cimzia).
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Executive Order Calls for Realignment of Childhood Vaccines
2
Embedded Pharmacists Are Vital Yet Underutilized in Diabetes Care
3
The Prodigious PBM Pivot: How Supply Chain Entities Will Move Forward After CAA 2026
4
Q&A: Pharmacists Can Address ADA Standards Across All Settings
5





























































